Tirzepatide (CAS No. 2023788-19-2)

Dual GIP/GLP-1 Receptor Agonist API for Type 2 Diabetes and Obesity

We supply pharmaceutical-grade Tirzepatide API manufactured to high quality standards for the development of injectable formulations. Tirzepatide is a dual GIP and GLP-1 receptor agonist that works through two complementary incretin pathways to support blood glucose control and body weight management. Thanks to its dual mechanism and once-weekly dosing profile, it has become an important peptide active ingredient in the treatment of type 2 diabetes mellitus (T2DM) and chronic weight management.

As a professional peptide API supplier, we provide high-purity Tirzepatide with strict quality control, reliable batch consistency, and flexible supply capacity for pharmaceutical companies, formulation developers, and research institutions.

Product Information

Product Overview

Tirzepatide is a novel peptide API designed to activate both GIP and GLP-1 receptors. By targeting these two incretin pathways at the same time, it helps regulate glucose metabolism, insulin secretion, glucagon release, gastric emptying, appetite, and body weight.

Compared with single-pathway incretin therapies, Tirzepatide offers a broader mechanism of action and has drawn strong interest in the development of therapies for metabolic disorders. Its long half-life also supports once-weekly administration, making it well suited for injectable dosage forms.

Applications

1. Type 2 Diabetes Mellitus

Tirzepatide is widely used in the development of therapies for patients with type 2 diabetes, particularly where improved glycemic control is required. It may be used as monotherapy or in combination with other antidiabetic agents such as metformin, SGLT2 inhibitors, or insulin-based regimens, depending on the formulation strategy and clinical application.

In addition to blood glucose management, Tirzepatide has also attracted attention for its potential benefits in broader cardiometabolic management, including support for weight reduction and improvement of related metabolic risk factors.

2. Chronic Weight Management

Tirzepatide is also an important active ingredient in the development of therapies for obesity and overweight patients with weight-related comorbidities. Through the combined action of GIP and GLP-1 receptor activation, it helps reduce appetite and support body weight control, making it a valuable peptide API for chronic weight management formulations.

Dosage Form Development

Tirzepatide is primarily used in the development of once-weekly injectable formulations for subcutaneous administration. It is suitable for applications such as pre-filled pens and other peptide injection systems. Different strength options may be developed according to formulation and market requirements.

Quality Assurance

Quality is critical for peptide APIs, especially for injectable applications. Our Tirzepatide is manufactured under strict process controls to ensure purity, identity, stability, and batch-to-batch consistency.

Raw Materials and Manufacturing

We use carefully selected starting materials and advanced peptide synthesis technology to support high product quality. Production is carried out in controlled facilities using solid-phase peptide synthesis (SPPS), followed by purification and lyophilization under strict operating standards.

Key process parameters, including coupling efficiency, impurity control, purification performance, and final drying conditions, are closely monitored throughout production to ensure consistent quality.

Testing and Release Standards

Each batch is tested according to internal quality standards and customer requirements. Available testing items may include:

HPLC purity and related substances

Peptide identity confirmation

Moisture content

Residual solvent analysis

Heavy metal testing

Endotoxin testing

Microbial limits

Other injectable-grade quality control items upon request

Supporting documents such as COA, analytical data, and technical documentation are available for qualified customers.

Safety and Handling

Tirzepatide is intended for pharmaceutical manufacturing, formulation development, and research use by qualified professionals only. Appropriate handling procedures should be followed during storage, processing, and formulation.

Because this is a highly active peptide ingredient, manufacturers should evaluate formulation compatibility, dosing design, excipient selection, reconstitution behavior, and long-term stability during product development.

Supply Capacity and Service

We supply Tirzepatide API for a wide range of development and manufacturing needs, from R&D quantities to larger commercial-scale orders. We work with pharmaceutical companies, contract manufacturers, formulation developers, and research organizations worldwide.

Our service support includes:

Stable API supply

Flexible order quantities

Technical documentation support

COA and quality-related documents

Packaging options for different project stages

Technical communication for formulation and storage requirements

Contact Us

If you are looking for a reliable Tirzepatide API supplier, please contact us for product details, technical documents, quotation, and supply support.

Email: sales@huarongpharma.com
Phone / WhatsApp: +86 13751168070

We look forward to working with global partners on high-quality peptide API supply and long-term cooperation.

FAQ

1. What is Tirzepatide used for?

Tirzepatide is a dual GIP/GLP-1 receptor agonist used as an active pharmaceutical ingredient in the development of therapies for type 2 diabetes and chronic weight management.

2. What are the main advantages of Tirzepatide?

Its key advantages include a dual incretin mechanism, support for glycemic control and weight management, and a long half-life that allows for once-weekly administration in injectable formulations.

3. What dosage forms can Tirzepatide be used in?

Tirzepatide is mainly used in subcutaneous injectable formulations, including pre-filled pen systems and other once-weekly injection products.

4. What quality documents can you provide?

For qualified customers, we can provide documents such as COA, purity data, analytical reports, and other technical information based on project requirements.

5. What order quantities do you support?

We support flexible quantities ranging from small R&D samples to larger bulk orders, depending on customer needs and project stage.